Hélou Josiane, Maatouk Ismaël, Moutran Roy, Obeid Grace, Stephan Farid
Department of Dermatology, Hôtel-Dieu de France Hospital, Faculty of medicine, Saint Joseph University, Beirut, Lebanon.
J Cutan Aesthet Surg. 2013 Jan;6(1):30-2. doi: 10.4103/0974-2077.110094.
Fractionated carbon dioxide (CO2) lasers are a new treatment modality for skin resurfacing. The cosmetic rejuvenation market abounds with various injectable devices (poly-L-lactic acid, polymethyl-methacrylate, collagens, hyaluronic acids, silicone). The objective of this study is to examine the efficacy and safety of 10,600-nm CO2 fractional laser on facial skin with previous volume injections.
This is a retrospective study including 14 patients treated with fractional CO2 laser and who have had previous facial volume restoration. The indication for the laser therapy, the age of the patients, previous facial volume restoration, and side effects were all recorded from their medical files. Objective assessments were made through clinical physician global assessment records and improvement scores records. Patients' satisfaction rates were also recorded.
Review of medical records of the 14 patients show that five patients had polylactic acid injection prior to the laser session. Eight patients had hyaluronic acid injection prior to the laser session. Two patients had fat injection, two had silicone injection and one patient had facial thread lift. Side effects included pain during the laser treatment, post-treatment scaling, post-treatment erythema, hyperpigmentation which spontaneously resolved within a month. Concerning the previous facial volume restoration, no granulomatous reactions were noted, no facial shape deformation and no asymmetry were encountered whatever the facial volume product was.
CO2 fractional laser treatments do not seem to affect facial skin which had previous facial volume restoration with polylactic acid for more than 6 years, hyaluronic acid for more than 0.5 year, silicone for more than 6 years, or fat for more than 1.4 year. Prospective larger studies focusing on many other variables (skin phototype, injected device type) are required to achieve better conclusions.
分次二氧化碳(CO2)激光是一种用于皮肤表面重塑的新治疗方式。美容年轻化市场充斥着各种可注射设备(聚左旋乳酸、聚甲基丙烯酸甲酯、胶原蛋白、透明质酸、硅胶)。本研究的目的是探讨10600纳米CO2分次激光对先前进行过容量注射的面部皮肤的疗效和安全性。
这是一项回顾性研究,纳入了14例接受分次CO2激光治疗且先前进行过面部容量恢复的患者。从他们的病历中记录激光治疗的适应症、患者年龄、先前的面部容量恢复情况以及副作用。通过临床医生整体评估记录和改善评分记录进行客观评估。还记录了患者的满意度。
对14例患者病历的回顾显示,5例患者在激光治疗前注射了聚乳酸。8例患者在激光治疗前注射了透明质酸。2例患者进行了脂肪注射,2例进行了硅胶注射,1例患者进行了面部线雕。副作用包括激光治疗期间的疼痛、治疗后脱屑、治疗后红斑、色素沉着,这些在一个月内自行消退。关于先前的面部容量恢复,无论使用何种面部容量产品,均未观察到肉芽肿反应,未出现面部形状变形和不对称。
CO2分次激光治疗似乎不会影响先前使用聚乳酸进行面部容量恢复超过6年、使用透明质酸超过0.5年、使用硅胶超过6年或使用脂肪超过1.4年的面部皮肤。需要进行前瞻性的更大规模研究,关注许多其他变量(皮肤光型、注射设备类型),以得出更好的结论。